NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $320,452 | +0.9% | 3,146 | 0.0% | 0.22% | +3.9% |
| Q2 2023 | $317,463 | +9.7% | 3,146 | 0.0% | 0.21% | +3.5% |
| Q1 2023 | $289,432 | +3.3% | 3,146 | +1.9% | 0.20% | -2.9% |
| Q4 2022 | $280,143 | +18.7% | 3,088 | -0.6% | 0.21% | +12.6% |
| Q3 2022 | $236,000 | +15.1% | 3,107 | +33.0% | 0.18% | +39.7% |
| Q1 2022 | $205,000 | +0.5% | 2,336 | 0.0% | 0.13% | +3.1% |
| Q4 2021 | $204,000 | +41.7% | 2,336 | +40.6% | 0.13% | +4.1% |
| Q3 2019 | $144,000 | -16.8% | 1,662 | -12.2% | 0.12% | -19.2% |
| Q2 2019 | $173,000 | -1.7% | 1,892 | +3.4% | 0.15% | -5.6% |
| Q1 2019 | $176,000 | +11.4% | 1,830 | 0.0% | 0.16% | -1.2% |
| Q4 2018 | $158,000 | 0.0% | 1,830 | 0.0% | 0.16% | +16.5% |
| Q3 2018 | $158,000 | +13.7% | 1,830 | 0.0% | 0.14% | +7.8% |
| Q2 2018 | $139,000 | – | 1,830 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |